1. .
   COVID-19 vaccine immunogenicity in people with HIV: Erratum.
   AIDS 2023;37:559.
   


2. .
   HTPN 078: an enhanced case management study to achieve viral suppression among viremic HIV-positive men who have sex with men in the United States: Erratum.
   AIDS 2023;37:557.
   


3. Munoz-Muela E, Ruiz-Mateos E, Gutierrez-Valencia A, Lopez-Cortes LF, et al.
   Response to: Reply to: Anti-CD4 autoantibodies in immunological nonresponder people living with HIV: cause of CD4+ T cell depletion?
   AIDS 2023;37:554-555.
   


4. Luo Z, Jiang W.
   Reply to: Anti-CD4+ autoantibodies in immunological non-responder people with HIV: cause of CD4+ T-cell depletion?
   AIDS 2023;37:553-554.
   


5. Woolley I, Boccara F.
   Primary cardiovascular prevention in people with HIV: what's the score?
   AIDS 2023;37:547-548.
   


6. Lyall H, Cote H, Flynn PM.
   Days and weeks do matter: a call for testing infants at risk of HIV acquisition at birth.
   AIDS 2023;37:545-546.
   


7. Fichtenbaum CJ, Mallon P.
   Are we ready to RESPOND that the question of abacavir's role in cardiovascular disease events is settled?
   AIDS 2023;37:541-543.
   


8. Dasgupta S, Beer L, Lu JF, Weiser J, et al.
   Needs for shelter or housing assistance among people with diagnosed HIV by jurisdiction: United States, 2015-2020.
   AIDS 2023;37:535-540.
   


9. Davies C, Vaida F, Otwombe K, Cotton MF, et al.
   Longitudinal comparison of insulin resistance and dyslipidemia in children with and without perinatal HIV infection in South Africa.
   AIDS 2023;37:523-533.
   


10. Patten GE, Euvrard J, Anderegg N, Boulle A, et al.
    Advanced HIV disease and engagement in care among patients on antiretroviral therapy in South Africa: results from a multi-state model.
    AIDS 2023;37:513-522.
    


11. Cluver LD, Zhou S, Orkin M, Rudgard W, et al.
    Impacts of intimate partner violence and sexual abuse on antiretroviral adherence among adolescents living with HIV in South Africa.
    AIDS 2023;37:503-511.
    


12. Portwood C, Sexton H, Kumarendran M, Brandon Z, et al.
    Perinatal outcomes associated with combination antiretroviral therapy compared with monotherapy.
    AIDS 2023;37:489-501.
    


13. Siegel DA, Thanh C, Wan E, Hoh R, et al.
    Host variation in type I interferon signaling genes (MX1), C-C chemokine receptor type 5 gene, and major histocompatibility complex class I alleles in treated HIV+ noncontrollers predict viral reservoir size.
    AIDS 2023;37:477-488.
    


14. Mondesert E, Reynes J, Makinson A, Bargnoux AS, et al.
    Cystatin C in addition to creatinine for better assessment of glomerular renal function decline in people with HIV receiving antiretroviral therapy.
    AIDS 2023;37:447-454.
    


15. Anderson K, Iyun V, Eley BS, Rabie H, et al.
    Hospitalization among infants who initiate antiretroviral therapy before 3 months of age.
    AIDS 2023;37:435-445.
    


16. Novitsky V, Steingrimsson J, Howison M, Dunn CW, et al.
    Not all clusters are equal: dynamics of molecular HIV-1 clusters in a statewide Rhode Island epidemic.
    AIDS 2023;37:389-399.
    


17. Castillo-Rozas G, Lopez MN, Soto-Rifo R, Vidal R, et al.
    Enteropathy and gut dysbiosis as obstacles to achieve immune recovery in undetectable people with HIV: a clinical view of evidence, successes, and projections.
    AIDS 2023;37:367-378.
    


18. Raccagni AR, Mileto D, Galli L, Bruzzesi E, et al.
    HIV viral load monitoring during monkeypox virus infection among PLWH.
    AIDS 2023.
    


19. .
    Correction to: Principles for Ending Human Immunodeficiency Virus as an Epidemic in the United States: A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association.
    Clin Infect Dis 2023.
    


20. Sowah LA, Smeaton L, Brates I, Bhattacharya D, et al.
    Perspectives on Adherence from the ACTG 5360 MINMON Trial: A Minimum Monitoring Approach with 12 Weeks of Sofosbuvir/Velpatasvir in Chronic Hepatitis C Treatment.
    Clin Infect Dis 2023.
    


21. Avery EF, Kleynhans JN, Ledergerber B, Schoepf IC, et al.
    Leukocyte Count and Coronary Artery Disease Events in People with HIV: A Longitudinal Study.
    Clin Infect Dis 2023.
    


22. English D, Smith JC, Scott-Walker L, Lopez FG, et al.
    Feasibility, Acceptability, and Preliminary HIV Care and Psychological Health Effects of iTHRIVE 365 for Black Same Gender Loving Men.
    J Acquir Immune Defic Syndr 2023.
    


23. Cummings MJ, Bakamutumaho B, Jain K, Price A, et al.
    Detection of urine lipoarabinomannan is associated with pro-inflammatory innate immune activation, impaired host defense, and organ dysfunction in adults with severe HIV-associated tuberculosis in Uganda.
    J Acquir Immune Defic Syndr 2023.
    


24. Benki-Nugent S, Tamasha N, Mueni A, Laboso T, et al.
    Early antiretroviral therapy reduces severity but does not eliminate neurodevelopmental compromise in children with HIV.
    J Acquir Immune Defic Syndr 2023.
    


25. Toure F, Etheredge GD, Brennan C, Parris K, et al.
    Retention and Predictors of Attrition Among HIV-infected Children on Antiretroviral Therapy in Cote d'Ivoire Between 2012 and 2016.
    Pediatr Infect Dis J 2023.
    


26. Aung A, Cui A, Maiorino L, Amini AP, et al.
    Low protease activity in B cell follicles promotes retention of intact antigens after immunization.
    Science 2023;379:eabn8934.
    

Display articles in

• Abstract format
• Medline format